

Researchers have long questioned why 40% of children with the rare neurodevelopmental condition KBG syndrome had heart problems. A new, ground-breaking study provides answers. There is now strong evidence between the brain and the heart.
Unusual facial development, skeletal deformities, cerebral underdevelopment, and cardiac issues are all possible side effects of KBG syndrome. Mutations in the ANKRD11 gene, which is essential for brain development, produce the condition. However, it was not until recently that researchers at the University of Alberta discovered a connection between the gene and cardiac issues, such as issues with heart valves and interventricular walls.
Leading the study was Anastassia Voronova, an associate professor in the Faculty of Medicine and Dentistry, working with a team from the U of A’s Core Research Facilities with state-of-the-art Vizgen Merscope equipment.
The ANKRD11 gene is essential for proper heart development. Voronova’s team found that mice lacking this gene in their neural crest cells had abnormal heart formation and function. These included enlarged heart ventricles, which hampered the heart’s ability to pump blood, and inefficient blood circulation as a result of the heart’s outflow tract not properly forming. A number of significant signaling pathways that influence cell growth and function were also impacted.
The study by this group builds on their earlier research, which was published earlier this year and demonstrated the significance of ANKRD11 for brain cell development. These mouse results were also observed in KBG disease patients, which resulted in the identification of a distinct clinical phenotype: olfactory deficiency.
In order to provide improved clinical care and therapy for children with KBG syndrome, the next stages involve examining how the heart and brain interact with one another during development. The results of the study and other recent research in this field have already begun to impact clinical procedures: children with KBG syndrome are now advised to have heart exams.
“The problem with rare disorders is that not all patients are evaluated the same way across the world. By showing a clear role of ANKRD11 in heart development, our work paves the way for including heart evaluations in clinical guidelines across the world. This will help to ensure every child diagnosed with KBG syndrome will have their heart evaluated and corrected in a timely manner if needed.”- Anastassia Voronova, Associate Professor in the Faculty of Medicine and Dentistry, University of Alberta
more recommended stories
New Study Questions Fluid Restriction in Heart Failure Management
A groundbreaking study presented at the.
Role of Leptin Signaling in the DMH for Metabolic Regulation
A groundbreaking study from the Pennington.
COVID-19 Vaccines May Lower the Risk of Long COVID by 27%
A recent rapid review suggests that.
3D-Printed Hydrogel for Meniscus Tear Treatment
Meniscus tears are one of the.
Machine Learning Predicts Early Mortality in IBD Patients
A groundbreaking study published in the.
Endometriosis Treatment Advances: Latest Research and Therapy
Recent endometriosis treatment advances are reshaping.
Lung Cancer Screening Gaps Persist Despite Updated Guidelines
A recent study led by researchers.
Altered Knee Movement After ACL Surgery May Trigger Early Osteoarthritis
A recent study published in the.
BRP Peptide for Weight Loss: A Natural Alternative to Ozempic?
The rising obesity epidemic has fueled.
Toxic Soil and Water Linked to Global Heart Disease Crisis
A groundbreaking review published in Atherosclerosis.
Leave a Comment